n-3 fatty acids (eicosapentanoic and docosahexanoic acids) in epilepsy and for the prevention of sudden unexpected death in epilepsy

Epilepsy and Behavior

Volumn 13, Issue 4, 2008, Pages 712-713

  DeGiorgio, C M ^a   Miller, Patrick ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ANTIARRHYTHMIC ACTIVITY; BRAIN INJURY; BRAIN PROTECTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EPILEPSY; EPILEPTIC STATE; EVIDENCE BASED MEDICINE; HEART ARRHYTHMIA; HEART INFARCTION; HEART RATE VARIABILITY; HUMAN; INTRACTABLE EPILEPSY; LETTER; LOW DRUG DOSE; NERVE CELL LESION; NONHUMAN; RECOMMENDED DRUG DOSE; RISK FACTOR; RISK REDUCTION; SEIZURE; SUDDEN DEATH;

DEATH, SUDDEN; EPILEPSY; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 54049132832     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.06.017     Document Type: Letter

References (16)

1. Bromfield E., Dworetzsky B., Huwitz S., et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav 12 (2008) 187-190
2. Yuen A.W., Sander J.W., Fluegel D., et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 7 (2005) 253-258
3. Xiao Y., and Li X. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res 846 (1999) 112-121
4. Yehuda S., Carasso R., and Mostofsky D. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 254 (1994) 193-198
5. Voskuyl R., Vregdenhil M., Kang J., et al. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 341 (1998) 145-152
6. Rabinovitz S., Mostofsky D., and Yehuda S. Anticonvulsant efficiency, behavioral performance, and cortisol levels: a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3). Psychoneuroendocrinology 29 (2004) 113-124
7. Ferrari D., Cysneiros R.M., Scorza C., et al. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav 13 (2008) 36-42
8. Scorza F.A. Preventive measures for sudden cardiac death in epilepsy beyond therapies. Epilepsy Behav 13 (2008) 263-264
9. Scorza F.A. The other side of the coin: beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav 13 (2008) 279-283
10. + channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 92 (1995) 11000-11004
11. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 94 (1997) 4182-4187
12. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI Prevenzione trial. Lancet 1999; 354:447-55.
13. Marchioli R., Barzi F., Bomba E., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Circulation 105 (2002) 1897-1903
14. Leaf A. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. J Cardiovasc Med 8 Suppl. 1 (2007) S27-S29
15. Kris-Etherton P.M., Harris W.S., and Appel L.J. For the Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
16. Ansakorpi H., Korpelainen J., Hikuri H., et al. Heart rate dynamics in refractory and well controlled temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 72 (2002) 26-30